Lung Cancer Clinical Trial

Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

Summary

This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria: The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:

unresectable primary or metastatic lung tumors
may benefit from multiple modalities of therapy
chemotherapeutic or radiation oncologic options have been exhausted

Exclusion Criteria:

1. co-existing morbidities that preclude the use of surgery

Study is for people with:

Lung Cancer

Study ID:

NCT00232128

Recruitment Status:

Terminated

Sponsor:

Oncology Specialties, Alabama

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Comprehensive Cancer Institute
Huntsville Alabama, 35801, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Study ID:

NCT00232128

Recruitment Status:

Terminated

Sponsor:


Oncology Specialties, Alabama

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.